Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Rapafusyn Pharmaceuticals licenses technology related to a novel class of natural product-like macrocycle.
NeuralGalaxy is a brain science company which is devoted to solve brain disorders.
Regenacy Pharmaceuticals Provides Healthcare Services.
UltraClear is a skincare clinic that provides facial rejuvenation solutions for the treatment of all skin types.
Dermaliq's mission is to develop and sell the next generation of dermatology treatments for patients with severe unmet medical needs.
Larkspur Biosciences is a biotechnology business that is developing the next generation of precision immunotherapies to combat cancer.
Arnatar Therapeutics is a biopharmaceutical company that specializes in the development of novel nucleic acid medications.
Myrobalan Therapeutics is a biotechnology company developing oral neurorestorative therapies for individuals with CNS diseases.
Clinical stage, novel technologies for managing Glaucoma
Cullgen is a drug discovery services intended to create new drugs for the treatment of diseases that currently lack effective therapies.
Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.
Lipidio Pharmaceuticals focuses on advancing a molecule to treat diseases associated with excess body fat.
OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for cancer treatment.
Tianhu Technology is a computational chemistry and AI-driven innovative drug molecule design provider.
CytoNiche is a 3D bionic cell technology company.
Xijian Technology is committed to advancing the industrialization of innovative human biomechanics imaging technology.
Sipeng Technology is a new form of synthetic biology high-tech company.
Junhemeng is a research and development company of recombinant protein drugs.
Novlead Biotech contributes to a safer and healthier human well-being through our technological innovations.
Cellbri is a manufacturing company that produces and sells automated CGT industrial instruments for cell processing programs.
Jushu Biotech is a medical engineering company that focuses on the research and development of synthetic biosensing technology.
Varnotech specializes in developing vaccines, antibodies, and adjuvants to combat diseases and viruses.
Ligatech Bioscience is an intrusive consumables developer .
Eluminex Biosciences is dedicated to the research and commercialization of novel therapies to address unmet medical needs.
3E Bioventures has invested in 41 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
3E Bioventures's top investment sectors include Biotechnology, Health Care, Medical, Biopharma, Pharmaceutical. The firm invests across 30 different industry categories.
Among tracked funding rounds, varnotech received $83.0M in a Series B round. 3E Bioventures's total known invested capital is $842.4M.
3E Bioventures's average investment size is $20.1M across its portfolio of 41 companies.
Recent 3E Bioventures portfolio additions include Rapafusyn Pharmaceuticals, NeuralGalaxy, Regenacy Pharmaceuticals, UltraClear, Dermaliq Therapeutics. These companies were founded in 2020 or later.